Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 50 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Christophe P.

United States

USD 50 /hr

Profile Summary

15+ years experience in the muscle field (aging, disease, injury) for in vivo and ex vivo gene therapy research in rodent. Expert in muscle behavior assay for mouse, in vivo techniques, IACUC protocol, in vivo design experiment

Subject Matter Expertise

• ☆ Animal Behavior/Ethology
• ☆ Animal Genetics
• ☆ Biochemical Assays

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Work Experience

Scientist

Stanford University

November 2018 - Present

Scientist

BMS

October 2017 - October 2018

Postdoc & research staff

Stanford University

September 2014 - October 2017

Postdoc & instructor

Emory University

February 2011 - August 2014

Education

PhD

Laval University

August 2005 - December 2010

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Ma, J., Pichavant, C., du Bois, H., Bhakta, M., Calos, M.P., Ma, J., Pichavant, C., du Bois, H., Bhakta, M., Calos, M.P.(2017). DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B . Molecular Therapy - Methods and Clinical Development. 7. p. 123-131.

Pichavant, C., Burkholder, T.J., Pavlath, G.K.(2016). Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress . Skeletal Muscle. 6. (1).

Simionescu-Bankston, A., Pichavant, C., Canner, J.P., Apponi, L.H., Wang, Y., Steeds, C., Olthoff, J.T., Belanto, J.J., Ervasti, J.M., Pavlath, G.K.(2015). Creatine kinase B is necessary to limit myoblast fusion during myogenesis . American Journal of Physiology - Cell Physiology. 308. (11). p. C919-C931.

Pichavant, C., Pavlath, G.K.(2014). Incidence and severity of myofiber branching with regeneration and aging . Skeletal Muscle. 4. (1).

Pichavant, C., Gargioli, C., Tremblay, J.P.(2011). Intramuscular transplantation of muscle precursor cells over-expressing MMP-9 improves transplantation success . PLoS Currents.

Pichavant, C., Aartsma-Rus, A., Clemens, P.R., Davies, K.E., Dickson, G., Takeda, S., Wilton, S.D., Wolff, J.A., Wooddell, C.I., Xiao, X., et al.(2011). Current status of pharmaceutical and genetic therapeutic approaches to treat DMD . Molecular Therapy. 19. (5). p. 830-840.

Pichavant, C., Chapdelaine, P., Cerri, D.G., Dominique, J.-C., Quenneville, S.P., Skuk, D., Kornegay, J.N., Bizario, J.C., Xiao, X., Tremblay, J.P.(2010). Expression of dog microdystrophin in mouse and dog muscles by gene therapy . Molecular Therapy. 18. (5). p. 1002-1009.

Pichavant, C., Chapdelaine, P., Cerri, D.G., Bizario, J.C.S., Tremblay, J.P.(2010). Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles . Human Gene Therapy. 21. (11). p. 1591-1601.

Chapdelaine, P., Pichavant, C., Rousseau, J., Pâques, F., Tremblay, J.P.(2010). Meganucleases can restore the reading frame of a mutated dystrophin . Gene Therapy. 17. (7). p. 846-858.

Stephan, L., Pichavant, C., Bouchentouf, M., Mills, P., Camirand, G., Tagmouti, S., Rothstein, D., Tremblay, J.P.(2006). Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use . Cell Transplantation. 15. (8-9). p. 835-846.

BOOK

Pichavant, C., Tremblay, J.P.(2012). Generation of lentiviral vectors for use in skeletal muscle research . Methods in Molecular Biology. 798. p. 285-295.